(Total Views: 260)
Posted On: 04/17/2019 3:29:39 PM
Post# of 149269
I agree the FDA likes leronlimab, with the great safety data and no documented resistance. I would hate to see if they didn't 
Complete new trial or worse, something like this:
https://www.cnbc.com/2019/04/08/zogenix-plumm...tment.html
Zogenix plummets 30% after FDA refuses to review its seizure treatment
Kind of like my initial thought reading a long's posts this morning:
"With shareholders like this, who needs enemies."
Complete new trial or worse, something like this: https://www.cnbc.com/2019/04/08/zogenix-plumm...tment.html
Zogenix plummets 30% after FDA refuses to review its seizure treatment
Kind of like my initial thought reading a long's posts this morning:
"With shareholders like this, who needs enemies."
(0)
(0)Scroll down for more posts ▼
